Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib
-
* Corresponding authors: Lixin Zheng LZHENG@niaid.nih.gov - Michael J Lenardo lenardo@nih.gov
BMC Medical Genetics 2007, 8:41 doi:10.1186/1471-2350-8-41
No comments have yet been made on this article.